Stereotactic Radiotherapy for Organ-confined Prostate Cancer: Early Toxicity and Quality of Life Outcomes from a Multi-institutional Trial

被引：6
|
作者：
Meier, R. [1 ]
Beckman, A. [2 ]
Kaplan, I. [3 ]
Mohideen, N. [4 ]
Shieh, E. [5 ]
Henning, G. [6 ]
Walz, B. [7 ]
Cotrutz, C. [1 ]
Sanda, M. [3 ]
机构：
[1] Swedish Canc Inst, Seattle, WA USA
[2] Cent Baptist Hosp, Lexington, KY USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] NW Community Hosp, Arlington Hts, IL USA
[5] Jupiter Med Ctr, Jupiter, FL USA
[6] St Joseph Mercy Hosp, Ypsilanti, MI USA
[7] St Louis Univ, St Louis, MO 63103 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2010.07.166
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [31] The PACE trial: International randomised study of laparoscopic prostatectomy vs. stereotactic body radiotherapy (SBRT) and standard radiotherapy vs. SBRT for early stage organ-confined prostate cancer.
    Morrison, Kirsty
    Tree, Alison
    Khoo, Vincent
    Van As, Nicholas John
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [32] Factors That Predict GU, GI, and Sexual Quality of Life (QOL) Outcomes 3 Years After Stereotactic Body Radiation Therapy (SBRT) for Early Prostate Cancer, Results From a Multi-institutional Phase 2 Trial
    Fuller, D. B.
    Wong, D.
    Medbery, C.
    Underhill, K.
    Chen, R. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S459 - S459
  • [33] Outcomes for oligometastatic head and neck cancer treated with stereotactic body radiotherapy: Results from an international multi-institutional consortium
    Said, Badr Id
    Mutsaers, Adam
    Chen, Hanbo
    Husain, Zain A.
    Biswas, Tithi
    Dagan, Roi
    Erler, Darby
    Foote, Matthew
    Louie, Alexander V.
    Redmond, Kristin
    Ricardi, Umberto
    Sahgal, Arjun
    Poon, Ian
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2023, 45 (10): : 2627 - 2637
  • [34] Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: The jury is still out
    DAmico, AV
    Coleman, CN
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) : 304 - 315
  • [35] Safety and tolerability of biodegradable balloon spacers in patients undergoing radiotherapy for organ-confined prostate cancer
    Topazio, Luca
    Narcisi, Federico
    Tana, Fabio
    Ciotta, Cosimo
    Iossa, Vincenzo
    Perna, Pasquale
    Chiaramonti, Francesco
    Romantini, Federico
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2023, 95 (02) : 35 - 38
  • [36] 5-year efficacy and quality of life outcomes of a multi-institutional HDR-Like prostate SBRT trial
    Fuller, D.
    Kane, B.
    Medbery, C.
    Underhill, K.
    Gray, J.
    Peddada, A.
    Chen, R.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S260 - S261
  • [37] Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials
    King, Christopher R.
    Freeman, Debra
    Kaplan, Irving
    Fuller, Donald
    Bolzicco, Giampaolo
    Collins, Sean
    Meier, Robert
    Wang, Jason
    Kupelian, Patrick
    Steinberg, Michael
    Katz, Alan
    RADIOTHERAPY AND ONCOLOGY, 2013, 109 (02) : 217 - 221
  • [38] 5-year outcomes from a prospective multi-institutional trial of heterogeneous dosing stereotactic body radiotherapy (SBRT) for low- and intermediate-risk prostate cancer.
    Fuller, Donald B.
    Kane, Brent L.
    Medbery, Clinton A.
    Underhill, Kelly
    Gray, James R.
    Peddada, Anuj
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [39] 10 Year Prostate Stereotactic Body Radiotherapy Outcomes: Relapse-free Survival, PSA Kinetics And Toxicity From A Pooled Analysis Of Two Multi-Institutional Trials
    Fuller, D. B.
    Chen, R. C.
    Crabtree, T.
    Kaplan, I. D.
    Meier, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E857 - E858
  • [40] Multi-institutional analysis of high-risk prostate cancer patients treated with stereotactic body radiotherapy.
    Jiang, Naomi Y.
    King, Christopher R.
    Katz, Alan J.
    Collins, Sean P.
    Aghdam, Nima
    Suy, Simeng
    Stephans, Kevin L.
    Reddy, Chandana A.
    Kaplan, Irving D.
    Appelbaum, Limor
    Dang, Audrey
    Yuan, Ye
    Nickols, Nicholas George
    Steinberg, Michael L.
    Kupelian, Patrick
    Kishan, Amar Upadhyaya
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
12345